Federal Court Reconsiders Cannabis’ Classification as a Schedule 1 Drug

As of May 30, news opinions are pressuring the DEA into conducting an administrative review as plaintiffs continue to insist on the life-altering health threats that the current scheduling of cannabis ensues.